Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and considered to be responsible for majority of worldwide prevalent dementia cases. The number of patients suffering from dementia are estimated to increase up to 115.4 million cases worldwide in 2050. Hence, AD is contemplated...
Main Authors: | Virendra Tiwari, Shubha Shukla |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1057068/full |
Similar Items
-
Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer’s dementia
by: Brandon Ebright, et al.
Published: (2022-10-01) -
Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer’s disease and vascular dementia
by: Xin Ying Chua, et al.
Published: (2023-12-01) -
Functional Characterization of Lysophospholipids by Proteomic and Lipidomic Analysis of Fibroblast-like Synoviocytes
by: Thomas Timm, et al.
Published: (2023-06-01) -
Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
by: Farida Dakterzada, et al.
Published: (2023-08-01) -
Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells
by: Lin Cheng, et al.
Published: (2020-01-01)